Company News, Regulations

FDA Warns L’Oréal

Food and Drug Administration targets L'Oréal for the third time in as many years over label claims.

Author Image

By: TOM BRANNA

Editor

The Food and Drug Administration has issued a warning letter to L'Oréal for its Rosalic AR Intense and Mela-D Pigment Control products. According to FDA, the products make drug claims under section 201(g)(1)(C) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(C)].  Specifically, FDA took umbrage with claims for Rosaliac AR Intense:   “Localized Redness Intensive Serum”  “RECOMMENDED FOR: Redness-prone skin, experiencing overall redness, flu...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters